News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade
Drew Moghanaki/LinkedIn
Sep 8, 2025, 09:35

Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade

Drew Moghanaki, Chief Medical Officer at Respirati, shared a post on X:

“A Norwegian study reveals a significant shift in the intent of radiation therapy treatments for NSCLC over the past decade, with a higher proportion prescribed for cure and less for palliation.”

Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade

Title: Changes in use of radiotherapy for lung cancer – A Norwegian population-based study from 2000 until 2020

Authors: Gustav Graabak, Tarje Onsøien Halvorsen, Bjørn Henning Grønberg, Kristin Toftaker Killingberg

Read The Full Article at Lung Cancer.

Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade

More posts featuring Drew Moghanaki on OncoDaily.

Bjørn Henning Grønberg cancer Drew Moghanaki Gustav Graabak Kristin Toftaker Killingberg OncoDaily Oncology Tarje Onsøien Halvorsen
Special Coverage
Science
Sep 8, 2025, 09:35
Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade
Science
Sep 8, 2025, 09:23
Bassam Sonbol: Randomized Phase II Trial of Pazopanib vs Placebo in Extrapancreatic NETs
Science
Sep 8, 2025, 09:06
Pat Soon-Shiong: Allowing Immune System to Cure the Cancer
Insight
Sep 8, 2025, 08:57
Andreas Charalambous: New Lancet Commission for Lung Cancer
Voices
Sep 8, 2025, 08:51
Roberto Ferrara: Tailoring Combination Treatments to ICI Resistance and Biomarkers
Voices
Sep 8, 2025, 08:44
Katy Beckermann: Strong Correlation Between Uptake and Tissue FAP Expression
Science
Sep 8, 2025, 08:34
Overall Survival with Amivantamab–Lazertinib in EGFR-Mutated Advanced NSCLC
Voices
Sep 8, 2025, 08:22
Vun-Sin Lim Highlights New IASLC Journals Lounge at WCLC25
Voices
Sep 8, 2025, 08:21
Ravindran Kanesvaran: The Best of Collaborative GU Oncology Education
Voices
Sep 8, 2025, 08:19
Harpreet Singh Showcases Biotech on the Main Stage at WCLC2025
Insight
Sep 8, 2025, 08:15
Don’t Miss the 6th Pakistan Pediatric Neuro-Oncology Symposium
Dialogues
Sep 8, 2025, 08:13
MASCC 2025 Presidential Training Fellowship Spotlight: Dr. Chia Jie Tan